A Drug-drug Interaction Study of SHR6390 on Healthy Chinese Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 1, 2021

Primary Completion Date

October 28, 2021

Study Completion Date

October 28, 2021

Conditions

Advanced Solid Tumor

Interventions

DRUG

SHR6390、efavirenz

SHR6390 tablet single dose；Efavirenz single dose.

Trial Locations (1)

Xuanwu Hospital Beijing, Capital Medical University, Beijing

All Listed Sponsors

lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT04973020 - A Drug-drug Interaction Study of SHR6390 on Healthy Chinese Volunteers | Biotech Hunter | Biotech Hunter